Brief: Pharmacolog I Uppsala Expects To Reduce Operating Costs By At Least 35% In Cost-Saving Programme
16/02/2024 08:03
Feb 16 (Reuters) - Pharmacolog I Uppsala AB (publ)
PHLOGb.ST :
* Q4 OPERATING LOSS SEK 4.2 MILLION VERSUS LOSS SEK 6.8
MILLION
YEAR AGO
* Q4 NET SALES SEK 2.6 MILLION VERSUS SEK 1.8 MILLION YEAR
AGO
* INITIATES COST-SAVING PROGRAMME WITH THE AIM OF
SIGNIFICANTLY
REDUCING THE ONGOING OPERATING COSTS
* IMPLEMENTATION OF COST REDUCTION MEASURES STARTS
IMMEDIATELY AND
WILL BE FULLY IMPLEMENTED IN Q1 2024
* AT FULL EFFECT, MEASURES WILL REDUCE OPERATING COSTS BY AT
LEAST
35% COMPARED TO THE OPERATING COSTS FOR THE FY 2022,
CORRESPONDING TO AT LEAST SEK 10 MILLION
Source text for Eikon: ID:nWkr25YVvg
Further company coverage: PHLOGb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))